Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results

Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results

[at noodls] – Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results Kyprolis Net Sales of $18.6 Million in Launch Quarter; Stivarga Launch Underway in U.S….This is an abstract of the original noodl. To … more

View todays social media effects on ONXX

View the latest stocks trending across Twitter. Click to view dashboard

Share this post